Contact this trialFirst, we need to learn more about you.
Peptide
BMN 111 for Achondroplasia
Recruiting1 awardPhase 2
Chicago, Illinois
This trial is to study the long-term effects of a medication given to children with achondroplasia, a form of dwarfism. The study will track the children's safety and tolerability of the medication over a period of time.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.